Chicago Rivet & Machine (CVR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
29 Sep, 2025Executive summary
Net sales for Q2 2024 were $8.06M, nearly flat year-over-year, with a $460K increase in assembly equipment sales offsetting a $452K decline in fastener sales.
Q2 2024 net income was $142K ($0.15/share) versus a net loss of $1.31M ($-1.36/share) in Q2 2023, driven by improved margins and cost controls.
For the first half of 2024, net sales declined 5.2% to $15.91M, with a net loss of $556K, a significant improvement from a $1.89M loss in the prior year period.
Financial highlights
Q2 2024 gross profit was $1.42M, up from a loss of $329K in Q2 2023, reflecting a 333% increase in fastener segment gross margin.
Selling and administrative expenses decreased 3.8% year-over-year in Q2 2024 to $1.31M.
Cash, cash equivalents, and short-term investments totaled $2.63M at June 30, 2024.
Working capital was $13.37M at June 30, 2024, down $609K from year-end 2023.
Regular quarterly dividend of $0.10/share paid in June 2024.
Outlook and guidance
Management does not anticipate significant changes in business conditions or demand in the second half of 2024 compared to the first half.
Focus remains on cost alignment, operating efficiency, and identifying new growth opportunities.
Latest events from Chicago Rivet & Machine
- Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing2 Dec 2025 - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 20257 Nov 2025 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 202429 Sep 2025 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 202429 Sep 2025 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 202529 Sep 2025 - Sales and margins declined in Q2 2025, raising going concern doubts despite cost actions.CVR
Q2 202529 Sep 2025